TrialEuropean journal of clinical pharmacology2025

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.